Midnight Daze
A boutique indica-leaning hybrid marketed for evening use, with more marketing lore than verified data behind it.
Midnight Daze is a small-batch hybrid you'll see on dispensary menus with poetic copy about 'sleepy euphoria.' The truth: there is no published chemistry data, no clinical trial, and no consistent genetic record for this name. What you actually get depends entirely on the grower. Treat the strain name as a loose marketing label, not a prescription. If sleep or relaxation is your goal, judge by the specific batch's lab report — not the name on the jar.
Overview
Midnight Daze is a cannabis strain name that appears on boutique dispensary menus and seed listings, typically marketed as an indica-dominant hybrid for evening or pre-sleep use. Unlike well-documented cultivars such as OG Kush or Blue Dream, Midnight Daze has no widely cited breeder of record, no consistent chemotype data across labs, and no meaningful presence in peer-reviewed cannabis literature. No data
What this means practically: two products labeled 'Midnight Daze' from different producers may share almost nothing in common besides the name. Cannabis strain names are not trademarked or standardized in most jurisdictions, and genetic testing has repeatedly shown that samples sold under the same name can differ substantially [1][2].
Chemistry
There is no aggregated public chemistry dataset for Midnight Daze. Individual dispensary Certificates of Analysis (COAs) circulating online report THC in the 18-22% range with negligible CBD, but these are single-batch snapshots, not population data. Weak / limited
Terpene profiles reported by vendors vary widely — some list myrcene-dominant profiles, others linalool or caryophyllene forward. Without a controlled chemotyping study, any claim about a 'signature' terpene profile is marketing, not science. The popular idea that a myrcene percentage above ~0.5% guarantees sedation is folklore that has been repeated widely online but is not established in the peer-reviewed literature [3]. Disputed
If you care about the actual chemistry of a specific jar, read that jar's COA. The strain name will not tell you.
Reported effects
Vendors and user forums describe Midnight Daze as relaxing, mildly euphoric, and conducive to sleep. These are consumer self-reports collected in uncontrolled settings, subject to expectancy effects, dose variability, and the placebo response — which is substantial for cannabis [4]. Anecdote
There are no clinical trials of Midnight Daze specifically. There are essentially no clinical trials of any named strain, because research protocols use standardized cannabinoid preparations, not dispensary flower [5]. Generalized effects associated with high-THC, low-CBD flower — relaxation, appetite increase, impaired short-term memory, possible anxiety at higher doses — apply here as they do to most similar products [6]. Strong evidence
The indica/sativa label predicting sedation vs. stimulation is not supported by chemical analysis; the two categories overlap heavily in cannabinoid and terpene content [7]. Strong evidence
Lineage
Reported lineages for Midnight Daze vary by seller. Some list it as a cross involving Granddaddy Purple and a Haze variant; others cite unrelated parents. No breeder has published a verifiable pedigree with dated seed releases or genetic markers. Disputed
This is the norm rather than the exception for newer boutique strain names. Independent genotyping studies have found that a large fraction of commercially named strains do not cluster genetically the way their marketed lineages would predict [1]. Treat any specific parent-strain claim about Midnight Daze as unverified unless the seller can produce breeding records or genetic testing.
Cultivation basics
Because no authoritative breeder documentation exists, cultivation notes are drawn from grower reports on forums and seed-bank listings. Commonly reported traits: Anecdote
- Flowering time: 8-9 weeks indoors under a 12/12 schedule.
- Structure: Medium height, indica-leaning bush habit with moderate lateral branching.
- Yield: Moderate indoors, roughly 400-450 g/m² for experienced growers.
- Environment: Prefers moderate humidity; dense buds may be susceptible to botrytis in humid finishes.
- Nutrients: No unusual requirements reported.
If you are sourcing seeds or clones, ask for the specific cut's provenance. 'Midnight Daze' from one nursery is not guaranteed to be the same plant as 'Midnight Daze' from another.
Marketing vs. reality
The marketing story around Midnight Daze — moody name, sleep positioning, indica label — is doing most of the heavy lifting. The reality:
- Name doesn't guarantee chemistry. Two jars can differ dramatically. Always read the COA.
- 'Indica for sleep' is a heuristic, not a rule. Modern chemotype research does not support indica/sativa as reliable predictors of effect [7].
- Terpene marketing outpaces evidence. Specific terpene-to-effect claims (linalool = sleep, limonene = uplift) come mostly from essential oil research at doses far higher than what you inhale from flower [3][8]. Weak / limited
- Lineage claims are usually unverifiable. Absent breeder records or genetic testing, take them as branding.
None of this means Midnight Daze is a bad product. It means the name carries very little information. Judge by the lab report, the grower's reputation, and — for your own body — a small test dose.
Sources
- Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. (2015). The Genetic Structure of Marijuana and Hemp. PLoS ONE 10(8): e0133292.
- Peer-reviewed Schwabe AL, McGlaughlin ME (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa. Journal of Cannabis Research 1:3.
- Peer-reviewed Russo EB (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 163(7): 1344-1364.
- Peer-reviewed Gukasyan N, Strain EC (2020). Relationship between cannabis use frequency and major depressive disorder in adolescents. Drug and Alcohol Dependence 208:107867. (For placebo/expectancy in cannabis studies see also: Zeiger et al. 2019).
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.
- Peer-reviewed MacCallum CA, Russo EB (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine 49: 12-19.
- Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N (2022). The phytochemical diversity of commercial Cannabis in the United States. PLoS ONE 17(5): e0267498.
- Peer-reviewed Finlay DB, Sircombe KJ, Nimick M, Jones C, Glass M (2020). Terpenoids from Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors. Frontiers in Pharmacology 11: 359.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Blue Dream — California's most-sold sativa-dominant hybrid, famous for balanced effects, easy growing,...
- Granddaddy Purple — A heavy, grape-scented indica from early-2000s California that became the template for mod...
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...
- OG Kush — The hazy-origin California strain that became the genetic backbone of modern American cann...